CLINICAL RESPONSES TO GEFITINIB RETREATMENT IN NON-SMALL-CELL-LUNG-CANCER ADENOCARCINOMA PATIENTS WHO BENEFITED FROM PRIOR EFFECTIVE GEFITINIB THERAPY: A RETROSPECTIVE ANALYSIS

被引：0
作者：
Li, Junling [1 ]
Yan, Wang [1 ]
Yuankai, Shi [1 ]
机构：
[1] Chinese Acad Med Sci, Canc Hosp & Inst, Beijing 100730, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
gefitinb; NSCLC; adenocarcinoma; readministration;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1291 / S1292
页数：2
相关论文
共 50 条
[21]   Gefitinib Alone or with Concomitant Whole Brain Radiotherapy for Patients with Brain Metastasis from Non-small-cell Lung Cancer: A Retrospective Study [J].
Zeng, Yin-Duo ;
Zhang, Li ;
Liao, Hai ;
Liang, Ying ;
Xu, Fei ;
Liu, Jun-Ling ;
Dinglin, Xiao-Xiao ;
Chen, Li-Kun .
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (03) :909-914
[22]   Gefitinib-Related Interstitial Lung Disease in Taiwanese Patients With Non-Small-Cell Lung Cancer [J].
Chang, Shih-Chieh ;
Chang, Cheng-Yu ;
Chang, Shu-Ju ;
Yuan, Mei-Kang ;
Lai, Yi-Chun ;
Liu, Yu-Chang ;
Chen, Cheng-Yu ;
Kuo, Li-Chiao ;
Yu, Chong-Jen .
CLINICAL LUNG CANCER, 2013, 14 (01) :55-61
[23]   Prolonged control of bone metastases in non-small-cell lung cancer patients treated with gefitinib [J].
Zampa, Germano ;
Moscato, Michele ;
Brannigan, Brian W. ;
Morabito, Alessandro ;
Bell, Daphne W. ;
Normanno, Nicola .
LUNG CANCER, 2008, 60 (03) :452-454
[24]   The efficacy and safety of lcotinib in patients with advanced non-small cell lung cancer: compare with gefitinib [J].
Zhang, Zhe ;
Wang, Qiming ;
Tang, Hong ;
Xia, Suhua ;
He, Zelai ;
He, Zhen ;
Wang, Lili ;
Zhu, Hui ;
Li, Shaomei ;
Wu, Yufeng .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (09) :18360-18366
[25]   Gefitinib as salvage therapy in pretreated patients with advanced non-small cell lung cancer. Data from a compassionate use program [J].
Gridelli, C ;
Rossi, A ;
Maione, P ;
Guerriero, C ;
Airoma, G ;
Colantuoni, G ;
Barzelloni, ML .
ANTICANCER RESEARCH, 2004, 24 (3B) :1873-1877
[26]   THE THERAPEUTIC OUTCOMES OF ERLOTINIB AFTER FAILURE OF GEFITINIB FOR PATIENTS WITH NON-SMALL CELL LUNG CANCER [J].
Matsunami, Keiji ;
Matsumoto, Shingo ;
Suyama, Hisashi ;
Kodani, Masahiro ;
Toge, Hirokazu ;
Kawasaki, Yuji ;
Igishi, Tadashi ;
Nakamura, Hiroshige ;
Shimizu, Eiji .
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) :S1241-S1241
[27]   Gefitinib versus docetaxel in treated non-small-cell lung cancer: a meta-analysis [J].
Wang, Bing ;
Zuo, Zhanjie ;
Li, Fang ;
Yang, Kun ;
Du, Minjun ;
Gao, Yushun .
OPEN MEDICINE, 2017, 12 (01) :86-91
[28]   Pooled analysis of the reports of erlotinib after failure of gefitinib for non-small cell lung cancer [J].
Kaira, Kyoichi ;
Naito, Tateaki ;
Takahashi, Toshiaki ;
Ayabe, Eriko ;
Shimoyama, Rai ;
Kaira, Rieko ;
Ono, Akira ;
Igawa, Satoshi ;
Shukuya, Takehito ;
Murakami, Haruyasu ;
Tsuya, Asuka ;
Nakamura, Yukiko ;
Endo, Masahiro ;
Yamamoto, Nobuyuki .
LUNG CANCER, 2010, 68 (01) :99-104
[29]   Histopathological and immunohistochemical features associated with clinical response to neoadjuvant gefitinib therapy in early stage non-small cell lung cancer [J].
Lara-Guerra, Humberto ;
Chung, Catherine T. ;
Schwock, Joerg ;
Pintilie, Melania ;
Hwang, David M. ;
Leighl, Natasha B. ;
Waddell, Thomas K. ;
Tsao, Ming-Sound .
LUNG CANCER, 2012, 76 (02) :235-241
[30]   A RETROSPECTIVE ANALYSIS OF THE CLINICAL RESPONSES TO EGFR-TYROSINE KINASE INHIBITOR (EGFR-TKI) CONTINUOUS TREATMENT BEYOND SINGLE SITE DISEASE PROGRESSION IN METASTATIC NON-SMALL CELL LUNG CANCER PATIENTS WHO BENEFITED FROM PRIOR EGFR-TKI THERAPY [J].
Parra, Hector J. Soto ;
Chiari, Rita ;
Bearz, Alessandra ;
Cavina, Raffaele ;
Spadaro, Pietro ;
Latteri, Fiorenza ;
Bordonaro, Roberto .
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) :S1254-S1254
12345